New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial
Cancer Patients Who Die In Hospital Or ICU Have Worse QOL; Caregivers Affected, Too
Rituximab Prolonged Survival Of CLL In Phase III Study
A Low-Cost Vaccine To Enter Clinical Trials In A Year
HPV DNA Testing Reduced Cervical Cancer Precursors
Targeting Men At High Risk Finds More Head & Neck Cancer
Half Of Mexican-Origin Women With Breast Cancer Diagnosed Before Age 50, Study Finds
Multivitamin Use Doesn’t Impact Outcomes, Study Finds
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- Franco Muggia, former head of CTEP and NYU cancer center, dies at 85
- House committee’s FY26 spending bill increases NCI funding by $48M, NIH by $99M
House joins Senate in rejecting Trump’s proposed 40% NIH cuts - Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group - Bhattacharya fields NCAB’s questions about funding, political involvement in grant review, DEI, animal testing
- Lowy: Forward-funding policy forced NCI to drastically reduce RPG awards funded for FY25, 10% of NCI staff has been lost
- Robert A. Winn on his new vision to train cancer center leaders: “I had a big bold idea and an ‘Aha!’ moment.”
